“Attacks on such targets would both hit large crowds and generate intensive media coverage,” the NDB spokesperson, Isabelle Graber, said in...

"As we look forward to next year, we just see so much need for primary vaccine, we are hearing it all over the world, and also boosters," M...

These are some of the sectors and stocks in traders’ sights for their roles in the global vaccine rollout.

Bank shares tracked a decline in bond yields, shrugging off signs of a pickup in M&A activity after a report said Italy's Banco BPM and Fra...

The Cambridge, Massachusetts-based company said the vaccine candidate, mRNA-1273, appeared to produce an immune response in eight people wh...

Moderna’s experimental shot induces the body’s own cells to make virus-like proteins that stimulate an immune response and prepare for an a...

Marchionne, who described himself as a corporate fixer, was Fiat’s fifth CEO in less than two years when he took over.

Alexandria Real Estate Equities, has separately sold Alexandria Knowledge Park at Genome Valley in Hyderabad for Rs 400 crore to Cerestra A...

Lonza Group AG agreed to buy Arch Chemicals Inc. for $1.2 billion in cash to create the world's biggest microbial - control business.

Piramal Healthcare will persist with its tested growth strategy of acquisitions to be counted among the world’s top five contract manufactu...